Indiabulls Housing, Suzlon among 417 stocks that hit upper circuit limit

Suven Life Sciences hit a record high of Rs 99.95 on Wednesday, having rallied 115 per cent thus far in December.

Topics
Buzzing stocks | Indiabulls Housing Finance Limited | Suzlon

SI Reporter  |  Mumbai 

Following the sharp run-up, returns are expected to plateau.
The stock of recently listed Burger King India (BKIL) was too locked in upper circuit of 20 per cent for the third straight day

Indiabulls Housing Finance, Himatsingka Seide, Suven Life Sciences, Affle (India), Yaarii Digital Integrated Services, Tejas Networks and Energy were among 417 stocks that were locked in their respective upper limits on the BSE on Wednesday following a strong rally in mid- and small-cap stocks.

Inox Wind, Prozone Intu Properties, Reliance Capital, Axiscades Technologies, Shivam Autotech, V2 Retail, Simplex Infrastructure, DB Realty, 3i Infotech and Vishal Fabrics from the S&P BSE Allcap index, too, hit their respective upper circuits on the BSE.

Shares of Dynacons Systems & Solutions hit upper circuit limit for the third straight day, up 20 per cent at Rs 78.30 after it won contracts worth Rs 24.51 crore for supply, installation and maintenance of HyperConverged Infrastructure and implementation of private cloud from the government-owned Union Bank of India. The stock of the information technology consulting & software company has rallied 70 per cent in the past three trading days.

The stock of recently listed Burger King India (BKIL) was too locked in upper circuit of 20 per cent for the third straight day, following a stellar debut on the bourses on Monday. The stock also hit a new high of Rs 199.25. On December 14, the scrip had closed at Rs 138.40, clocking a 130-per cent premium over its issue price of Rs 60. With the past two days' gain, the stock has rallied 232 per cent from its issue price.

Shares of Suven Life Sciences hit their upper circuit of 10 per cent for the second consecutive day. The stock was trading at Rs 99.95 during the day, also its all-time high. It has rallied 115 per cent so far in December.

In a clarification on its stock price movement, the pharmaceutical company said: "at this point of time, we do not have any material announcement/ event due for notification to the stock exchanges which may have a bearing on the price or volume behaviour of the scrip."

We request you to disseminate this clarification on your website for information to the general public, which is also being uploaded on our Company’s website, the company said in a BSE filing.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Buzzing stocks
First Published: Wed, December 16 2020. 15:11 IST
RECOMMENDED FOR YOU